AngioDynamics ANGO Payments To Acquire Intangible Assets Net Of Cash Acquired
Payments To Acquire Intangible Assets Net Of Cash Acquired at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept ango:PaymentsToAcquireIntangibleAssetsNetOfCashAcquired.
The official record: AngioDynamics’s 10-K, filed July 18, 2025, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's payments to acquire intangible assets net of cash acquired.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's payments to acquire intangible assets net of cash acquired?
- AngioDynamics (ANGO) reported payments to acquire intangible assets net of cash acquired of $0 in Q1 2025.
- How has AngioDynamics's payments to acquire intangible assets net of cash acquired changed year-over-year?
- AngioDynamics's payments to acquire intangible assets net of cash acquired decreased by 100.0% year-over-year, from $812.5K to $0.
- What does payments to acquire intangible assets net of cash acquired mean?
- These are cash outflows for the purchase of intellectual property, patents, licenses, or other non-physical assets. This metric highlights the company's commitment to R&D and inorganic growth by securing proprietary technology. It is a key indicator of how the company builds its competitive moat in the medical device sector.